This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Opportunities and counterintuitive challenges for decentralized clinical trials to broaden participant inclusion
npj Digital Medicine Open Access 05 May 2022
-
Indicators of retention in remote digital health studies: a cross-study evaluation of 100,000 participants
npj Digital Medicine Open Access 17 February 2020
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Smalley, E. Clinical trials go virtual, big pharma dives in. Nat Biotechnol 36, 561–562 (2018). https://doi.org/10.1038/nbt0718-561
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0718-561
This article is cited by
-
Opportunities and counterintuitive challenges for decentralized clinical trials to broaden participant inclusion
npj Digital Medicine (2022)
-
Indicators of retention in remote digital health studies: a cross-study evaluation of 100,000 participants
npj Digital Medicine (2020)